These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2886219

  • 21. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG.
    Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320
    [Abstract] [Full Text] [Related]

  • 22. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep 01; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 23. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
    Takeuchi Y, Fukumoto S, Matsumoto T.
    J Cell Physiol; 1995 Mar 01; 162(3):315-21. PubMed ID: 7860639
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 25. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells.
    Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massagué J.
    Nature; 1988 Jul 15; 329(6139):539-41. PubMed ID: 2889143
    [Abstract] [Full Text] [Related]

  • 26. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta.
    Topouzis S, Majesky MW.
    Dev Biol; 1996 Sep 15; 178(2):430-45. PubMed ID: 8830742
    [Abstract] [Full Text] [Related]

  • 27. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X, Bellis S, Yan Z, Friedman E.
    Cell Growth Differ; 1999 Jan 15; 10(1):11-8. PubMed ID: 9950213
    [Abstract] [Full Text] [Related]

  • 28. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M, Piccini D, Barbieri O, Astigiano S.
    Exp Cell Res; 1997 May 01; 232(2):304-12. PubMed ID: 9168806
    [Abstract] [Full Text] [Related]

  • 29. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
    Wilder PJ, Bernadt CT, Kim JH, Rizzino A.
    Mol Reprod Dev; 2002 Nov 01; 63(3):282-90. PubMed ID: 12237943
    [Abstract] [Full Text] [Related]

  • 30. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA, Ziober BL, Morris SL, Mulder KM.
    Cell Growth Differ; 1993 Aug 01; 4(8):637-45. PubMed ID: 8398905
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
    Zhou GH, Sechrist GL, Periyasamy S, Brattain MG, Mulder KM.
    Cancer Res; 1995 May 15; 55(10):2056-62. PubMed ID: 7743502
    [Abstract] [Full Text] [Related]

  • 32. Effects of endogenously activated transforming growth factor-beta on growth and differentiation of retinoic acid-treated HL-60 cells.
    Nunes I, Kojima S, Rifkin DB.
    Cancer Res; 1996 Feb 01; 56(3):495-9. PubMed ID: 8564960
    [Abstract] [Full Text] [Related]

  • 33. Type beta transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development.
    Mummery CL, van den Eijnden-van Raaij AJ.
    Int J Dev Biol; 1993 Mar 01; 37(1):169-82. PubMed ID: 8389576
    [Abstract] [Full Text] [Related]

  • 34. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB.
    Cancer Res; 1982 Nov 01; 42(11):4776-8. PubMed ID: 6290046
    [Abstract] [Full Text] [Related]

  • 35. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.
    Cancer Res; 2004 Nov 01; 64(21):7954-61. PubMed ID: 15520202
    [Abstract] [Full Text] [Related]

  • 36. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
    Miller K, Rizzino A.
    Cell Growth Differ; 1996 Feb 01; 7(2):203-11. PubMed ID: 8822204
    [Abstract] [Full Text] [Related]

  • 37. [The mechanism of vasculogenesis: the critical role of transforming growth factor-beta 1 in the formation of vessel-like structures during the differentiation in vitro of murine embryonic stem cells].
    Tsung HC, Yao Z.
    Shi Yan Sheng Wu Xue Bao; 1996 Sep 01; 29(3):273-85. PubMed ID: 9639813
    [Abstract] [Full Text] [Related]

  • 38. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE, Black B, Brattain MG.
    J Cell Physiol; 1989 Mar 01; 138(3):459-66. PubMed ID: 2925796
    [Abstract] [Full Text] [Related]

  • 39. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells.
    Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB.
    Cancer Res; 1984 Apr 01; 44(4):1635-41. PubMed ID: 6322983
    [Abstract] [Full Text] [Related]

  • 40. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y, Ono M, Yasutake C, Mawatari M, Kuwano M.
    J Cell Physiol; 1987 Jan 01; 130(1):51-7. PubMed ID: 3468117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.